Paper-based HIV self test
纸质 HIV 自检
基本信息
- 批准号:10373830
- 负责人:
- 金额:$ 47.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-25 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAddressBiological AssayBlood VolumeBlood capillariesCaringCatalytic DNACellular PhoneCenters for Disease Control and Prevention (U.S.)ClinicalClustered Regularly Interspaced Short Palindromic RepeatsComplexContractsCoupledCytolysisDNADataData SetDetectionDevelopmentDevicesDiagnosticDiseaseEmergency department visitEnsureEnzymesFeedbackFluorescenceGenetic MaterialsGoldGuidelinesHIVHIV AntibodiesHIV InfectionsHuman immunodeficiency virus testHumidityInfectionInterviewLaboratoriesManufacturer NameMasksMedical centerMethodsMolecularMonitorNanotechnologyNucleic AcidsPaperPatient RecruitmentsPatientsPerformancePhasePlasmaPlasma CellsPreparationProcessProductionRNARNA amplificationReactionReaderResearchRiskSamplingSensitivity and SpecificitySourceSpecificityStructureTemperamentTemperatureTestingUniversitiesValidationViralViral Load resultVirionVirusWhole BloodWorkamplification detectionantibody detectionantiretroviral therapybasecohortdesigndetection assaydetection limitgenomic RNAinnovationinstrumentationnovel strategiesoperationpathogenic virusperformance testspilot testprototypeself testingstability testingsuccessusabilityviral RNAviral detectionviral reboundwhole genome
项目摘要
Abstract: Current self-tests for HIV rely on detection of antibodies to the virus, and thus are not
useful during the early stages of infection. These assays are also not appropriate for patients on
antiretroviral therapy who may be at risk for viral rebound, as pre-existing anti-HIV antibodies
mask changes in viral load. Conversely, current HIV diagnostics based on detection of viral RNA
are sensitive, but too complex and expensive to be appropriate for self-testing. To address this
critical need, we will develop the first enzyme-free sample-to-answer HIV viral load self-test, in
which a fingerstick volume of blood is passively processed leading to amplification of the isolated
HIV genomic RNA. The RNA amplification strategy will rely on hairpin cascade reactions (HCR),
a DNA nanotechnology approach with proven single-copy sensitivity in other contexts, in a sessile
droplet implementation. The entire assay will be implemented in an inexpensive, disposable,
paper-based consumable. In the R61 phase, we propose to: (1) building on methods we have
previously validated, optimize passive processing of whole blood coupled with paper-based viral
lysis and RNA isolation; (2) complete development of HCR-based amplification of HIV genomic
RNA; (3) integrate sample processing and RNA amplification into a single consumable; and (4)
obtain feedback on assay design and usability from patients at risk for HIV infection, and develop
a pilot manufacturing plan. In the R33 phase, we will (1) scale production of the assay with
contract manufacturers in quantities suitable for pilot testing, and (2) complete testing of the assay
with a cohort of 1000 patients at-risk for HIV infection, recruited from patients visiting the
Emergency Department at the University of Rochester Medical Center.
摘要:目前的艾滋病毒自我检测依赖于病毒抗体的检测,因此不可行。
在感染的早期阶段很有用。这些测定也不适合患者
接受抗逆转录病毒治疗的人可能面临病毒反弹的风险,因为已有抗 HIV 抗体
掩盖病毒载量的变化。相反,当前的 HIV 诊断基于病毒 RNA 检测
很敏感,但过于复杂且昂贵,不适合自测试。为了解决这个问题
迫切需要,我们将开发第一个无酶样本来回答 HIV 病毒载量自检,
被动处理指尖血量,导致分离的扩增
HIV基因组RNA。 RNA扩增策略将依赖于发夹级联反应(HCR),
一种 DNA 纳米技术方法,在其他情况下,在固着中具有经过验证的单拷贝敏感性
液滴实施。整个测定将在一个廉价的、一次性的、
纸质耗材。在 R61 阶段,我们建议:(1)基于我们现有的方法
先前经过验证,优化全血的被动处理与纸基病毒相结合
裂解和 RNA 分离; (2) 完成基于HCR的HIV基因组扩增
核糖核酸; (3) 将样品处理和RNA扩增集成到单一耗材中;和(4)
从有 HIV 感染风险的患者那里获取有关检测设计和可用性的反馈,并制定
试点制造计划。在 R33 阶段,我们将 (1) 扩大检测规模生产
合同制造商的数量适合进行中试测试,以及 (2) 完成测定测试
一项由 1000 名有感染 HIV 风险的患者组成的队列,是从就诊的患者中招募的
罗切斯特大学医学中心急诊科。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin L Miller其他文献
A patch for a splice
一个用于接头的补片
- DOI:
10.1038/nchembio.1839 - 发表时间:
2015-06-17 - 期刊:
- 影响因子:13.700
- 作者:
Benjamin L Miller - 通讯作者:
Benjamin L Miller
Benjamin L Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin L Miller', 18)}}的其他基金
RNA Targeted Small Molecules: Connecting Binding Kinetics to Sequence Selectivity
RNA 靶向小分子:将结合动力学与序列选择性联系起来
- 批准号:
8550102 - 财政年份:2012
- 资助金额:
$ 47.2万 - 项目类别:
RNA Targeted Small Molecules: Connecting Binding Kinetics to Sequence Selectivity
RNA 靶向小分子:将结合动力学与序列选择性联系起来
- 批准号:
8737913 - 财政年份:2012
- 资助金额:
$ 47.2万 - 项目类别:
RNA Targeted Small Molecules: Connecting Binding Kinetics to Sequence Selectivity
RNA 靶向小分子:将结合动力学与序列选择性联系起来
- 批准号:
8259290 - 财政年份:2012
- 资助金额:
$ 47.2万 - 项目类别:
RNA Targeted Small Molecules: Connecting Binding Kinetics to Sequence Selectivity
RNA 靶向小分子:将结合动力学与序列选择性联系起来
- 批准号:
8914807 - 财政年份:2012
- 资助金额:
$ 47.2万 - 项目类别:
Preclinical Development of Lead Compounds Targeting Myotonic Dystrophy
针对强直性肌营养不良的先导化合物的临床前开发
- 批准号:
7963320 - 财政年份:2010
- 资助金额:
$ 47.2万 - 项目类别:
Preclinical Development of Lead Compounds Targeting Myotonic Dystrophy
针对强直性肌营养不良的先导化合物的临床前开发
- 批准号:
8109327 - 财政年份:2010
- 资助金额:
$ 47.2万 - 项目类别:
Photonic structures for direct ultrasensitive virus detection
用于直接超灵敏病毒检测的光子结构
- 批准号:
8029557 - 财政年份:2009
- 资助金额:
$ 47.2万 - 项目类别:
Photonic structures for direct ultrasensitive virus detection
用于直接超灵敏病毒检测的光子结构
- 批准号:
8238366 - 财政年份:2009
- 资助金额:
$ 47.2万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 47.2万 - 项目类别:
Research Grant